Prediction of Tumor Progression After Microwave Ablation of Hepatocellular Carcinoma by Contrast-Enhanced Ultrasound Combined with Immunohistochemical Markers
Journal of Hepatocellular Carcinoma · 2026-02 · Volume 13 · 1-15
DOI: 10.2147/jhc.s539184 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hepatocellular Carcinoma, 2026-02. Verfasst von Tian-Tian Dong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Ultrasound Medical Center, Lanzhou University Second Hospital, Lanzhou, 730030, People's Republic of China. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Purpose
By integrating imaging data, laboratory markers, and the expression of immunohistochemical (IHC) markers, a mode l was developed to predict tumor progression (TP) following microwave ablation (MWA) in hepatocellular carcinoma (HCC), offering a novel approach for evaluating treat ment efficacy in HCC patients. Patients and Methods: This retrospective study included 91 patients with stage 0 or stage A BCLC with single pathologically confirmed HCC who underwent ultrasound-guided percutaneous MWA. Imaging features, laboratory indicators (such as liver function indicators and tumor markers), and IHC markers were included. The correlation between these three indices and TP after tumor ablation was analyzed, and a prognostic model was constructed to explore the influence of multiple factors on the prognosis of tumors after MWA.
Results
Laboratory markers (Age-Platelet Index [API] and elevated pre-/post-ablation AFP/PIVKA-II) were significantly correlated with post-ablation TP (all p 200 ng/mL, post-ablation persistent AFP/PIVKA-II elevation, GPC-3/Arg-1/HSP 70 expression, and Ki-67 index as TP predictors. Multivariate analysis confirmed irregular morphology, API, AFP >200 ng/mL, GPC-3/HSP 70 expression, and the Ki-67 index as independent predictors. ROC analysis demonstrated the superior predictive performance of the multifactor model (AUC=0.995).
Conclusion
Tumor morphology, preoperative serum AFP levels (>200 ng/mL), positive expression of GPC-3, HSP 70, and Ki-67 were independent predictors of HCC relapse after ablation. The model constructed in combination with these predictors showed high diagnostic performance in predicting post-ablation progression of HCC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ultrasound Medical Center, Lanzhou University Second Hospital, Lanzhou, 730030, People's Republic of China.
- Gansu Province Clinical Research Center for Ultrasonography, Lanzhou, 730030, People's Republic of China.
- Gansu Province Medical Engineering Research Center for Intelligence Ultrasound, Lanzhou, 730030, People's Republic of China.
- Gansu Province Interventional Ultrasound Equipment Application Industry Technology Center, Lanzhou, 730030, People's Republic of China.
Zitieren
APA
Dong, T. T., Li, M., Li, Y. Y., Yin, C., & Nie, F. (2026). Prediction of Tumor Progression After Microwave Ablation of Hepatocellular Carcinoma by Contrast-Enhanced Ultrasound Combined with Immunohistochemical Markers. Journal of Hepatocellular Carcinoma, Volume 13, 1-15. https://doi.org/10.2147/jhc.s539184
Vancouver
Dong TT, Li M, Li YY, Yin C, Nie F. Prediction of Tumor Progression After Microwave Ablation of Hepatocellular Carcinoma by Contrast-Enhanced Ultrasound Combined with Immunohistochemical Markers. Journal of Hepatocellular Carcinoma. 2026;Volume 13:1-15. doi:10.2147/jhc.s539184
BibTeX
@article{Dong2026,
author = {Dong, Tian-Tian and Li, Ming and Li, Yuan-Yuan and Yin, Ci and Nie, Fang},
title = {Prediction of Tumor Progression After Microwave Ablation of Hepatocellular Carcinoma by Contrast-Enhanced Ultrasound Combined with Immunohistochemical Markers},
journal = {Journal of Hepatocellular Carcinoma},
year = {2026},
volume = {Volume 13},
pages = {1--15},
doi = {10.2147/jhc.s539184}
}
EUVIMED